Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults
Angiology
DOI:
10.1186/s12933-023-02004-1
Publication Date:
2023-10-21T13:02:20Z
AUTHORS (27)
ABSTRACT
Early diagnosis and treatment effectiveness of early-onset coronary artery disease (EOCAD) are crucial, non-invasive predictive biomarkers needed for young adults. We aimed to evaluate the usefulness triglyceride-glucose (TyG) index, a novel marker insulin resistance, in identifying CAD patients predicting their risk developing target lesion failure (TLF).We recruited EOCAD (luminal narrowing ≥ 70%) controls free from < 30%), both aged 45 years or younger, 38 hospitals China between 2017 2020. who underwent successful percutaneous intervention were followed incident TLF. TyG index was defined as Ln [fasting triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2]. used logistic regression Cox proportional hazards modeling association with prevalent TLF, respectively. The discriminatory ability assessed by area under receiver-operating characteristic curve (AUC).Among included 1513 (39.6 ± 4.4 years, 95.4% male) age-matched (39.0 46.4% male), positively associated prevalence (adjusted odds ratio: 1.40, 95% confidence interval [CI] 1.23-1.60, per standard deviation [SD] increase index). addition an empirical model provided improvement diagnostic EOCAD, net reclassification 0.10 (95% CI 0.03-0.17, p = 0.005). During medium 33 month (IQR: 31-34 months) follow-up, 43 (3.3%) experienced Multivariate revealed that independent factor TLF hazard ratio [HR]: 2.410, 1.07-5.42 comparing top bottom tertile groups; HR: 1.30, 1.01-1.73, SD Compared conventional factors alone, modestly improved AUC (0.722-0.734, 0.04) predict TLF.TyG is appeared be valuable component future efforts improve stratification outcome prediction among
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....